Performance of the Predicting Risk of Cardiovascular Disease Events Calculator in Rheumatoid Arthritis
PREVENT underestimates CVD risk in RA, consistent with suboptimal performance of existing risk calculators. Preferential use of PREVENT including hemoglobin A1c should be considered. Improving CVD risk stratification in RA remains a high priority.
Authors
- Amarnath Annapureddy (ORCID: https://orcid.org/0000-0002-9732-4903)
- Isaac D. Smith (ORCID: https://orcid.org/0000-0003-3313-4825)
- Gary A. Kunkel
- Tate Johnson (ORCID: https://orcid.org/0000-0001-9290-6464)
- T. Mikuls
- Beth Wallace (ORCID: https://orcid.org/0000-0003-1802-1427)
- Kaveh Rezaei Bookani (ORCID: https://orcid.org/0000-0002-8476-5005)
- Halie Frideres (ORCID: https://orcid.org/0009-0008-1752-0949)
- Bryant R England
- Brian C Sauer
- Punyasha Roul
- Thomas R Porter
- Joshua F Baker
- Grant W Cannon
Institutions
- University of Michigan (US)
- VA Salt Lake City Healthcare System (US)
- Michigan Medicine (US)
- VA Center for Clinical Management Research (US)
- Durham VA Health Care System (US)
- Philadelphia VA Medical Center (US)
- University of Utah Health Care (US)
- VA Nebraska Western Iowa Health Care System (US)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- Arthritis & Rheumatology
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1002/art.70081
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- U.S. Department of Veterans Affairs
- Rheumatology Research Foundation
- Health Services Research and Development
- National Institute of General Medical Sciences